Detalhe da pesquisa
1.
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Haematologica
; : 0, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855029
2.
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Ann Intern Med
; 174(10): 1420-1429, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516270
3.
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 42(17): 1698-1706, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760027
4.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
N Engl J Med
; 378(7): 615-624, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231094
5.
ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism.
Cardiol Young
; 31(8): 1213-1219, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344494
6.
Clinical implications of incidental venous thromboembolism in cancer patients.
Eur Respir J
; 55(2)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727694
7.
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
J Endovasc Ther
; 25(2): 158-168, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29552984
8.
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Lancet
; 388(10055): 1995-2003, 2016 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27590218
9.
Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.
Circulation
; 131(1): 82-90, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403645
10.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
N Engl J Med
; 369(15): 1406-15, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991658
11.
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Vasc Med
; 21(4): 361-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27165711
12.
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.
Crit Care
; 20(1): 273, 2016 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659071
13.
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
J Endovasc Ther
; 22(2): 261-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809373
14.
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study.
J Thromb Haemost
; 21(10): 2929-2940, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178771
15.
Use of PER977 to reverse the anticoagulant effect of edoxaban.
N Engl J Med
; 371(22): 2141-2, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371966
16.
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.
Clin Pharmacol Drug Dev
; 11(5): 666-674, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877813
17.
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
J Am Coll Cardiol
; 80(24): 2301-2310, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328157
18.
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
Eur Heart J Cardiovasc Pharmacother
; 8(7): 695-706, 2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962979
19.
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.
Res Pract Thromb Haemost
; 6(5): e12748, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992565
20.
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
J Thromb Haemost
; 19(12): 3008-3017, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455706